Discover emerging life sciences companies
The Early-Stage Innovation Forum (ESIF) is Australia’s premier showcase for emerging life sciences innovation, providing researchers, entrepreneurs and early-stage companies with the opportunity to present breakthrough technologies, receive expert commercialisation feedback and connect with Australia’s leading life sciences ecosystem.
From innovations in biotechnology, medical technology, digital health, diagnostics, precision medicine, research tools or enabling technologies, the Early-Stage Innovation Forum provides a platform to companies looking to accelerate their commercialisation journey.
The Early-Stage Innovation Forum is part of the AusBiotech International Conference’s investment stream and will be presented on Wedensday October 21st from 2.15pm.
The Early-Stage Innovation Forum is proudly sponsored by:
Represented by CEO Craig Phillips, will present technology focused on revealing disease-relevant function in living neurons.
Led by CEO and Managing Director Stephen Blakeney, is developing an approach to sperm selection designed to better reflect natural biological processes.
Represented by COO Dr Lydia Liuw, is working to enhance the effectiveness of cancer radiotherapy.
Founded and led by Dr Fanny Blaudez, will present a novel non-invasive blood test being developed to diagnose endometriosis, determine its severity and help guide treatment.
From the Frazer Institute at The University of Queensland, Associate Professor Fernando Guimaraes will showcase an Anti-ROR1 Antibody Platform.
Led by CEO Ellen Gonda, is working to radically improve the IVF patient experience and treatment success
Represented by CEO Chris Alma, is developing an approach to turn RNA signals into precision medicines.
Represented by founder Mark Appleford, is seeking to unlock the next generation of long-acting therapeutics by reinventing PLGA.
Two separate innovations being commercialised through UniQuest will feature. Dr Rebecca Faleiro will present a first-in-class dual NaV1.1/NaV1.7 peptide platform for chronic visceral pain, while Kurt Harris will present work on an anti-Tau antibody for Alzheimer’s disease.
From WEHI, research engineer Mihin Perera will showcase technology aimed at delivering effective and affordable plunge freezing for cryo-electron microscopy.
Led by CEO Denzil Furtado, is working on technology designed to transport medicines safely and reliably across the blood-brain barrier.
The Early-Stage Innovation Forum includes:
The Early-Stage Innovation Forum is designed to help Australia’s most promising life sciences innovations move from discovery towards commercialisation.
Unlike traditional investor pitch events, ESIF provides a supportive environment where researchers and founders can showcase their innovation, receive expert feedback and build valuable industry connections before embarking on larger fundraising activities.
For thos developing a novel therapeutic, medical device, diagnostic, digital health platform or enabling technology, ESIF helps accelerate the commercialisation journey.
Presenting companies will:
To be considered for 2027 events, submit your innovation to AusBiotech’s Investment Readiness Platform (IRP) now.
The IRP helps life sciences innovators strengthen their translation pathway and funding readiness, from early non-dilutive support through to future capital conversations.
Apply through our Investor Readiness Platform to be considered for this year-round program. Apply here.
The Investor Readiness Platform application consists of a short form and a supporting deck or summary.
Submissions that meet Early-Stage Innovation Forum eligibility are progressed for consideration.
Applicants are notified if invited to present.
Find out more about the Investor Readiness Platform and how to submit your application.
